Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Project Name | Project Stage | Molecule Type | Host Species | Therapeutic Area | Indications |
CLDN6 mAb - 01 | PCC | Solid Tumor | Ovarian cancer,Lung adenocarcinoma |
Cat . Non | Espèces | Description du produit | Structure | Pureté | Caractéristique |
---|---|---|---|---|---|
CHEK-ATP138 | Human | HEK293/Human Claudin-6 Stable Cell Line | |||
CL6-H52P7 | Human | Human Claudin-6 / CLDN6 Full Length Protein (VLP) | |||
CL6-HF2G8 | Human | Fluorescent Human Claudin-6 / CLDN6 Full Length Protein (VLP) | |||
CL6-HF2M9 | Human | Fluorescent Human Claudin-6 / CLDN6 Protein, Flag,His,GFP Tag (Nanodisc) |
|
||
CL6-H5286 | Human | Human Claudin-6 / CLDN6 Protein, His,Twin-Strep Tag (Nanodisc) |
|
||
CL6-H5289 | Human | Human Claudin-6 / CLDN6 Protein, His,Twin-Strep Tag (Detergent) |
|
2e5 of anti-Claudin-6 CAR-293 cells were stained with 100 μL of 1 μg/mL of Fluorescent Human Claudin-6 Protein, Flag,His,GFP Tag (Cat. No.CL6-HF2M9) and negative control protein respectively (Fig. A and B), FITC signal was used to evaluate the binding activity (QC tested).
Human Claudin-6 Full Length Protein (VLP) (Cat. No. CL6-H52P7) captured on L1 Chip can bind Anti-Claudin-6 Antibody, Human IgG1 with an affinity constant of 57.8 pM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
IMAB-027 | ASP-1650; IMAB-027 | Phase 2 Clinical | Ganymed | Ovarian Neoplasms; Neoplasms; Neoplasms, Germ Cell and Embryonal | Details |
BNT-142 | BNT-142 | Phase 2 Clinical | Biontech Se | Solid tumours | Details |
NBL-028 | NBL028; NBL-028 | Phase 1 Clinical | Shanghai Xinshi Biological Medicine Co Ltd, Novarock Biotherapeutics Ltd | Solid tumours; Ovarian Neoplasms; Stomach Neoplasms; Neoplasms; Testicular Neoplasms; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
XmAb-541 | XmAb541; XmAb-541 | Phase 1 Clinical | Xencor Inc | Ovarian Neoplasms; Ovarian germ cell tumor; Germinoma; Endometrial Neoplasms; Neoplasms, Germ Cell and Embryonal | Details |
CLDN6-CAR-NK Cell Therapy | Phase 1 Clinical | Second Affiliated Hospital Of Guangzhou Medical University | Ovarian Neoplasms; Testicular Neoplasms; Endometrial Neoplasms | Details | |
DS-9606a | DS-9606a; DS-9606-a | Phase 1 Clinical | Daiichi Sankyo Inc | Ovarian Neoplasms; Neoplasms; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal | Details |
AMG-794 | AMG-794 | Phase 1 Clinical | Amgen Inc | Carcinoma, Ovarian Epithelial; Carcinoma, Non-Small-Cell Lung | Details |
TORL-1-23 | TORL-1-23 | Phase 1 Clinical | Torl Biotherapeutics LLC | Solid tumours; Ovarian Neoplasms; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
CLDN6 CAR-T cell therapy (BioNTech) | BNT-211 | Phase 1 Clinical | Biontech Se | Solid tumours | Details |
IMAB-027 | ASP-1650; IMAB-027 | Phase 2 Clinical | Ganymed | Ovarian Neoplasms; Neoplasms; Neoplasms, Germ Cell and Embryonal | Details |
BNT-142 | BNT-142 | Phase 2 Clinical | Biontech Se | Solid tumours | Details |
NBL-028 | NBL028; NBL-028 | Phase 1 Clinical | Shanghai Xinshi Biological Medicine Co Ltd, Novarock Biotherapeutics Ltd | Solid tumours; Ovarian Neoplasms; Stomach Neoplasms; Neoplasms; Testicular Neoplasms; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
XmAb-541 | XmAb541; XmAb-541 | Phase 1 Clinical | Xencor Inc | Ovarian Neoplasms; Ovarian germ cell tumor; Germinoma; Endometrial Neoplasms; Neoplasms, Germ Cell and Embryonal | Details |
CLDN6-CAR-NK Cell Therapy | Phase 1 Clinical | Second Affiliated Hospital Of Guangzhou Medical University | Ovarian Neoplasms; Testicular Neoplasms; Endometrial Neoplasms | Details | |
DS-9606a | DS-9606a; DS-9606-a | Phase 1 Clinical | Daiichi Sankyo Inc | Ovarian Neoplasms; Neoplasms; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal | Details |
AMG-794 | AMG-794 | Phase 1 Clinical | Amgen Inc | Carcinoma, Ovarian Epithelial; Carcinoma, Non-Small-Cell Lung | Details |
TORL-1-23 | TORL-1-23 | Phase 1 Clinical | Torl Biotherapeutics LLC | Solid tumours; Ovarian Neoplasms; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
CLDN6 CAR-T cell therapy (BioNTech) | BNT-211 | Phase 1 Clinical | Biontech Se | Solid tumours | Details |
This web search service is supported by Google Inc.